tirzepatide vs semaglutide side effects comparison study Semaglutide vs. Tirzepatide: Mental Health Effects Tirzepatide versus Semaglutide Once Weekly

Sources MOUNJARO (tirzepatide) Injection, for subcutaneous use (2022) Zepbound (tirzepatide) Injection, for subcutaneous use (2022) Tirzepatide Once Weekly for the Treatment of Obesity (June 4, 2022) Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (May 11, 2025)

Obesity is a serious, common chronic disease among older Americans and Wegovy is the only weight management medicine proven to reduce the risk of major heart events, heart attack, stroke, or cardiovascular death in people with obesity and known heart disease

With population-based data scarce, the researchers set out to help provide more evidence

it's calibrated to your specific biology, circumstances, and goals